Urokinase-Type Plasminogen Activator Binding to Its Receptor Stimulates Tumor Cell Migration by Enhancing Integrin-Mediated Signal Transduction
- 10 July 1999
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 250 (1), 231-240
- https://doi.org/10.1006/excr.1999.4510
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- CAS/Crk Coupling Serves as a “Molecular Switch” for Induction of Cell MigrationThe Journal of cell biology, 1998
- Signaling through focal adhesion kinaseBioEssays, 1997
- Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell MigrationJournal of Biological Chemistry, 1996
- Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinomaInternational Journal of Cancer, 1996
- Integrins as promiscuous signal transduction devicesImmunology Today, 1996
- Blockage of urokinase receptor reduces in vitro the motility and the deformability of endothelial cellsFEBS Letters, 1996
- Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.Journal of Clinical Investigation, 1995
- Integrins: Emerging Paradigms of Signal TransductionAnnual Review of Cell and Developmental Biology, 1995
- Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient miceNature, 1995
- Urokinase-Urokinase Receptor Interaction: Non-Mitogenic Signal Transduction in Human Epidermal CellsBiochemical and Biophysical Research Communications, 1993